查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1208608

2023-2030 年全球口蹄疫疫苗市场

Global Foot and Mouth Disease Vaccines Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

2023 年全球口蹄疫疫苗市场规模预计为 28.743 亿美元，预测期内（2023-2030 年）的复合年增长率为 8.6%。

DNA 测试，通常称为基因测试，是一种医学测试，可以检测人类基因、染色体或蛋白质的变化。 这些突变可以揭示一个人是否患有遗传病。 DNA 测试还可以确定您感染某些疾病或遗传遗传问题的风险。 DNA 测试是可选的。 是否接受测试是一个复杂的个人问题，因为测试有其优点、缺点和风险。 遗传学家或遗传咨询师可以通过概述测试的优缺点并检查其社会和情感影响来提供帮助。

市场动态

推动全球口蹄疫疫苗市场发展的主要因素包括全球对动物产品的需求不断增长、积极的政府项目、不断增加的研发支出以及不断增长的全球动物数量导致了口蹄疫的发展-口病疫苗市场.东西等

全球对畜产品的需求不断增长预计将推动市场增长。

对牛奶、家禽、鸡蛋、纺织品和高科技机械等畜产品的需求不断增长，正在改变畜牧业并吸引大规模投资。 用于减少动物损失的主要策略之一是接种疫苗。 如果让受感染的动物死亡，政府和私人动物公司所有者将面临巨大的经济损失。 口蹄疫疫苗是必不可少的，因为没有永久性的治疗方法，而且感染的可能性很大。

肉食问题因 2022 年中期世界各地经历的异常气候事件而凸显出来，尤其是创纪录的高温和俄罗斯入侵乌克兰引发的能源危机。 根据 2022 年发表在医学杂誌《柳叶刀》上的一篇关于英国肉类趋势的论文，全球人均消费量和总消费量都在增加。 人口增长、财富增加以及重视吃肉的社会文化规范是造成这一激增的原因之一。

根据这篇文章，“不同人群对肉类消费和瘦肉的态度各不相同，以年龄、性别、种族和收入为特征。” 文章进一步强调，各国内部存在肉类消费的不平等。 最新的粮食及农业组织 (FAO) 粮食展望调查发现，儘管生产环境充满挑战，动物疾病流行、衝突和投入成本上升，但 2022 年全球肉类生产将放缓。预计将增加。

高成本预计会阻碍市场增长。

但是，高疫苗储存成本预计会抑制市场扩张。

COVID-19 影响分析

自 2019 年 12 月爆发 COVID-19 病毒以来，该病已蔓延至 100 多个国家，2020 年 1 月 30 日，世界卫生组织宣布其为突发公共卫生事件。 COVID-19 的经济影响主要有三方面：对其他药品和疫苗供需的直接影响、分配系统的中断以及对製造商的经济影响。。 包括中国、印度、沙特阿拉伯、阿拉伯联合酋长国和埃及在内的许多国家普遍实行封锁，这使得将药品从一个地方转移到另一个地方变得困难重重。

但是，COVID-19 大流行损害了全球口蹄疫免疫市场，因为行业巨头抓住了宝贵的机会来製造可以保护动物的 COVID-19（冠状病毒）疫苗。 例如，2020 年 4 月，中国生物製药公司 Sinovac Biotech 的科学家给八隻恆河猴注射了两剂该公司的 COVID-19 疫苗。 三週后，COVID-19 病毒通过管子穿过猴子的气管进入猴子的肺部，但没有人出现全面感染。

内容

第一章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第四章市场动态

  • 市场影响因素
    • 司机
      • 全球对畜产品的需求增加
      • 积极的政府项目
    • 约束因素
      • 高成本预计会阻碍市场增长。
    • 机会
    • 影响分析

第五章行业分析

  • 波特的五力分析
  • 供应链分析
  • 定价分析
  • 监管分析

第 6 章 COVID-19 分析

  • COVID-19 市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按产品类型

  • 常规疫苗
  • 紧急疫苗

第 8 章动物类型

  • 奶牛
  • 山羊
  • 猪
  • 绵羊
  • 其他

第 9 章分销渠道

  • 兽医医院
  • 宠物诊所

第10章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第11章竞争格局

  • 主要发展和战略
  • 公司股票分析
  • 产品基准
  • 值得关注的主要公司名单

第12章公司简介

  • 勃林格殷格翰国际有限公司
    • 公司简介
    • 产品组合和说明
    • 主要亮点
    • 财务摘要
  • Merck and Co., Inc
  • China Agricultural Vet. Bio. Science and Technology
  • Biogenesis Bago SA
  • Indian Immunologicals Ltd
  • Vecol S.A.
  • Brilliant Bio Pharma Private Limited
  • Limor de Colombia
  • FGBI-ARRIAH
  • QYH Biotech.

第13章 DataM

简介目录
Product Code: DMVH1523

Market Overview

The global foot and mouth disease vaccines market size was valued at US$ 2,874.3 million in 2023 and is estimated to reach US$ XX million by 2030, growing at a CAGR of 8.6% during the forecast period (2023-2030).

A DNA test, often known as genetic testing, is a medical examination that can spot changes in human genes, chromosomes, or proteins. These mutations can reveal if a person has a genetic disorder or not. DNA tests can also determine a person's risk of contracting a certain illness or passing along a genetic problem. Testing for DNA is optional. Whether to be tested is complex and personal because there are advantages to testing and drawbacks and risks. A geneticist or genetic counselor can assist by outlining the advantages and disadvantages of the test and by going over its social and emotional implications.

Market Dynamics

The major factors driving the global foot and mouth disease vaccines market the the rise in the global demand for animal products, positive governmental projects, increasing research and development spending, and the foot and mouth disease vaccine market will develop as the animal population increases globally.

The rise in the global demand for animal products is expected to drive the market's growth.

The growing demand for animal goods, including milk, chicken, eggs, mefabrics, andl as high-tech machinery, are some drivers changing the animal business and luring massive investment. One of the main strategies used to reduce animal loss is vaccination. Governments and private animal company owners risk suffering significant financial losses if affected animals are put to death. Due to the lack of a permanent treatment and the numerous ways in which contamination might happen, the FMD vaccine is essential.

The issue of meat eating has come up due to the extraordinary climatic occurrences experienced around the world in mid-2022, most notably record-high temperatures and the energy crisis brought on by Russia's invasion of Ukraine. According to a 2022 article on meat trends in the U.K. published in the medical journal The Lancet, the average quantity of meat consumed per person and the total amount consumed is increasing globally. Population expansion increased wealth, and sociocultural norms that place a high value on eating meat are all blamed for this surge.

According to the article, "attitudes towards meat consumption and meat reduction differ within segments of the population, as characterized by age, gender, ethnicity, or income." The article goes on to underline that inequalities in meat consumption also exist within countries. The newest Food Outlook study from the U.N. Food and Agriculture Organization (FAO) predicts that global meat output will increase moderately in 2022, despite a difficult production environment characterized by widespread animal illnesses, conflicts, and rising input costs.

Expensive cost is expected to hamper the market's growth.

However, high vaccine storage costs are anticipated to restrain market expansion.

COVID-19 Impact Analysis

The disease has spread to over 100 nations since the COVID-19 viral epidemic in December 2019, and on January 30, 2020, the World Health Organization proclaimed it a public health emergency. The three primary ways that COVID-19 can affect the economy include directly impacting the supply and demand for other medications and vaccines, causing disruptions in the distribution system, and having an economic impact on manufacturers. Many nations, including China, India, Saudi Arabia, the United Arab Emirates, Egypt, and others, have difficulty moving pharmaceuticals from one location to another due to widespread lockdowns.

The COVID-19 pandemic, however, harms the global market for foot and mouth disease vaccinations since major firms in the industry are grabbing value-grab chances to create COVID-19 (coronavirus) vaccines that can protect animals. For instance, in April 2020, scientists from the Chinese biopharmaceutical company Sinovac Biotech Ltd. administered two doses of its COVID-19 vaccine to eight rhesus macaques. The COVID-19 virus was inserted into the monkeys' lungs through tubes down their tracheas three weeks later, but none developed a full-blown infection.

Segment Analysis

The cattle segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The animal type segment is the highest market holder in the global foot and mouth disease vaccines market. The huge population of cattle worldwide and the domination of cattle farming as a major source of income for people in many nations are the main causes of the rise of the livestock segment. For instance, the likelihood of contracting an infection would be higher in nations with big cattle populations, such as China and Mexico. The Food and Agriculture Organization (FAO) predicted in September 2021 that India's national herd would increase by 1.2 million head from the Italy cattle count in 2021 to reach 306.7 million animals in 2022.

One of the most contagious illnesses in cattle is FMD. It threatens the world's cow population and has resulted in significant financial losses. Although this disease was successfully eradicated in the U.S. in 1929, several other nations are currently engaged in this conflict. The market growth may be boosted by OIE (World Organization for Animal Health) campaigns like the Southeast Asia Foot and Mouth Disease Campaign (SEAFMDC).

The introduction of immunization programs for cattle by various organizations is also anticipated to fuel the segment's expansion. For instance, the Prayagraj animal husbandry began a huge campaign to immunize cows and other cattle against foot and mouth disease in August 2020. Due to the rising demand for better and healthier meat, there is growing awareness of zoonoses and diseases affecting cattle. Therefore, these variables will have a favorable impact on the market in the years to come.

Geographical Analysis

North America holds the largest market share in the global Foot And Mouth Disease Vaccines market.

North America dominates the global foot and mouth disease vaccines market primarily due to excellent medical infrastructure, and high-income levels. Due to the widespread implementation of benefits for animal healthcare in the region, the North American region is one of the largest contributors to the vaccine market against foot and mouth disease. A combination of sophisticated animal healthcare programs and increased public awareness of animal health is expected to fuel the market's rapid growth in the region.

Additionally, the prevalence of animal diseases is driving up the demand for quick and efficient treatment alternatives, which is anticipated to drive the market's growth over the forecast period. For instance, it was indicated in the December 2021 article titled "Foreign animal disease concern: foot and mouth disease" that foot and mouth disease was a condition that needed to be reported in the United States. Foot and mouth disease decimates the cattle business in the U.S. and results in catastrophic losses that harm the economy and animal welfare. Foot and mouth disease's impact on animal welfare is anticipated to increase demand for efficient immunization.

Additionally, it is anticipated that several market players will continue to create new products, fueling the market's expansion in this area. To permit the production of the foot and mouth disease vaccine in the United States, for instance, Zoetis, Inc. submitted a petition to the Animal and Plant Health Inspection Services in August 2020. Thus, it is anticipated that the abovementioned elements will fuel market expansion in this area during the projection year.

Competitive Landscape

The foot and mouth disease vaccines market is moderately competitive with local and global companies' presence. Boehringer Ingelheim International GmbH, Merck and Co., Inc, China Agricultural Vet. Bio. Science and Technology, Biogenesis Bago SA, Indian Immunologicals Ltd

Vecol S.A., Brilliant Bio Pharma Private Limited, Limor de Colombia, FGBI-ARRIAH, QYH Biotech and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in October 2022,a new animal vaccine production plant is being built in Hyderabad by Indian Immunologicals (IIL), a division of the National Dairy Development Board (NDDB), with an investment of Rs 700 crore. The facility's ability to produce 600 million annual doses of the Foot and Mouth disease (FMD) vaccine will be doubled.

Boehringer Ingelheim International GmbH.

Overview: A division of CH Boehringer Sohn AG & Co KG, Boehringer Ingelheim International GmbH (Boehringer) is a pharmaceutical firm that develops, produces, and sells medicines, parasiticides, vaccines, and therapies for unmet medical needs. It provides a wide range of products, including biopharmaceuticals, animal health care items, and treatments for human ailments. The company's medications are used, among other things, to treat diseases of the immune system, the cardiovascular and metabolic systems, the respiratory system, cancer, and the retina. Additionally, it provides animal healthcare items for pigs, ruminants, poultry, horses, and other species.

Product Portfolio:

Aftopor: Aftopor, Aftovaxpur, and Aftobov Oleosa, three FMD vaccines with highly powerful and purified antigens, may offer marker features that allow difference between infected and vaccinated animals (DIVA) for endemic or emergency situations. Only use Aftovaxpur Doe in dire circumstances.

The global Foot And Mouth Disease Vaccines market report would provide access to approx.: 45+market data table, 40+figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The rise in the global demand for animal products
      • 4.1.1.2. Positive governmental projects.
    • 4.1.2. Restraints:
      • 4.1.2.1. Expensive cost is expected to hamper the market's growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Supply Chain Analysis
  • 5.3 Pricing Analysis
  • 5.4 Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Conventional Vaccines
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Emergency Vaccines

8. By Animal Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
    • 8.1.2. Market Attractiveness Index, By Animal Type
  • 8.2. Cattle
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Goat
  • 8.4. Pig
  • 8.5. Sheep
  • 8.6. Others

9. By Distribution Channel

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.1.2. Market Attractiveness Index, By Distribution Channel
  • 9.2. Veterinary Hospitals
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Pet Clinics

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size AnalysisUS$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Products Benchmarking
  • 11.4. List of Key Companies to Watch

12. Company Profiles

  • 12.1. Boehringer Ingelheim International GmbH
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Merck and Co., Inc
  • 12.3. China Agricultural Vet. Bio. Science and Technology
  • 12.4. Biogenesis Bago SA
  • 12.5. Indian Immunologicals Ltd
  • 12.6. Vecol S.A.
  • 12.7. Brilliant Bio Pharma Private Limited
  • 12.8. Limor de Colombia
  • 12.9. FGBI-ARRIAH
  • 12.10. QYH Biotech.

LIST NOT EXHAUSTIVE

13. Global Foot And Mouth Disease Vaccines Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Application
  • 13.3. Contact Us